Assignee
GUANGDONG TCRCURE BIOPHARMA TECH CO LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
4 records- 0173US2025243293A1Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpointsGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 0261US2021369776A1Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpointsGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2019·Application pending·0 cites
- 0355US2022125845A1Anti-alpp car-t cell therapyGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 0451US2023227527A1Tcr-t cell therapy targeting epstein-barr virusGUANGDONG TCRCURE BIOPHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GUANGDONG TCRCURE BIOPHARMA TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →